Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration
Crossref DOI link: https://doi.org/10.1007/s00280-016-3192-6
Published Online: 2016-11-30
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sy, S. Kenneth
Sweeney, Theresa D.
Ji, Chunmei
Hoch, Ute
Eldon, Michael A.
License valid from 2016-11-30